Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells

Journal of Clinical Oncology

Volumn 14, Issue 9, 1996, Pages 2521-2526

  Bishop, M R ^a   Jackson, J D ^a   O'Kane Murphy, B ^a   Schmit Pokorny, K ^a   Vose, J M ^a   Bierman, P J ^a   Warkentin, P I ^a   Armitage, J O ^a   Garrison, L ^a   Kessinger, A ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; MILODISTIM; MITOXANTRONE;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; BURST FORMING UNIT; CANCER IMMUNOTHERAPY; CELL TRANSPLANTATION; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMATION; DRUG SAFETY; FEVER; HUMAN; HUMAN CELL; HUMAN TISSUE; MYALGIA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SYMPTOMATOLOGY; THROMBOCYTE TRANSFUSION;

EID: 9544240331     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.9.2521     Document Type: Article

References (17)

1. To LB, Haylock DN,Thorp D et al: The optimization of collection of peripheral blood stem cells for autotransplantation in acute myeloid leukaemia. Bone Marrow Transplant 4:41-47, 1989
2. Kessinger A, Armitage JO, Smith DM et al: High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 74:1260-1265, 1989
3. To LB, Shepperd KM, Kimber RJ et al: Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp Hematol 18:442-447, 1990
4. Korbling M, Martin H: Transplantation of hemapheresis-derived hemopoietic stem cells: A new concept in the treatment of patients with malignant lymphohemopoietic disorders. Plasma Ther Transfus Technol 9:119-132, 1988
5. Socinski MA, Cannistra SA, Elias A et al: Granulocyte-macro-phage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1:1194-1198, 1988
6. Bishop MR, Anderson JR, Jackson JD et al: High-dose therapy and peripheral blood progenitor transplantation: Effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft. Blood 83:610-616, 1994
7. Sheridan WP, Begley CG, Juttner CA, et al: Effect of peripheral-blood progenitor cells mobilized by G-CSF on platelet recovery after high-dose chemotherapy. Lancet 339:640-644, 1992
8. Vose JM, Kessinger A, Bierman PJ et al: The use of rhIL-3 for mobilization of peripheral blood stem cells in previously treated patients with lymphoid malignancies. Int J Cell Clon 10:62-65, 1992 (suppl 1)
9. Williams D, Park LS: Hematopoietic effects of a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein. Cancer 67:2705-2707, 1991 (suppl)
10. Metcalf D: The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood 67:257, 1986
11. Kessinger A, Vose JM, Bierman PJ, Armitage JO: High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: An alternative to bone marrow purging. Exp Hematol 19:1013-1018, 1991
12. Jackson JD, Letheby B, O'Kane-Murphy B, et al: Kinetics of low and high dose granulocyte-macrophage colony stimulating factor mobilization of peripheral blood, in Worthington-White DA, Gee AP, Gross S (eds): Bone Marrow Purging and Processing. New York, NY, Wiley-Liss, 1994, pp 471-477
13. Philip T, Armitage JO, Spitzer G, et al: High dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or high grade non-Hodgkin's lymphoma. N Engl J Med 316:1493-1498, 1987
14. Reese DE, Connors JM, Spinelli JJ, et al: Intensive therapy with cyclophosphamide, carmustine, etoposide ± cisplatine, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy. Blood 83:1193-1199, 1994
15. Demirer T, Buckner CD, Lilleby K: Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous stem cell transplantation to improve outcome in relapsed disease. Cancer 74:715-721, 1994
16. Spitzer G, Adkins DR, Spencer V, et al: Randomized study of growth factors post-peripheral-blood stem-cell transplant: Neutrophil recovery is improved with modest clinical benefit. J Clin Oncol 12:661-670, 1994
17. Bishop MR, Anderson JR, Vose JM, et al: High-dose chemotherapy and peripheral blood progenitor cell transplantation: Effects of granulocyte-macrophage colony stimulating factor on the autograft, in Dicke KA, Keating A (eds): Autologous Marrow and Blood Transplantation, vol 7. Proceedings of the Seventh International Symposium, Arlington, TX, 1994, pp 563-572